ClinicalTrials.gg
Drug

Fenfluramine clinical trials

Also written Fintepla and ZX008.

studies test it
22
open now
5
in phase 3
11
first study started
2016

How each study uses Fenfluramine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Fenfluramine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Jun 2020 · FINTEPLA · NDA 212102 (FDA, Drugs@FDA)
European Union
18 Dec 2020 · Fintepla · EMEA/H/C/003933 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fenfluramine
10
Fenfluramine Hydrochloride
6
ZX008 (Fenfluramine Hydrochloride)
5
fenfluramine HCl
2

Brand

Fintepla
4

Development codes

ZX008
4
ZX0008
1

Studies by the year they started

21 studies that test it; most in 2016 (3)

Studies that test Fenfluramine, by start year
YearStudies
20163
20173
20181
20193
20211
20222
20232
20243
20263

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
3
Phase 3
11
Phase 4
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 11

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. (6) · UCB BIOSCIENCES, Inc. (3) · Zogenix, Inc. (2) · KU Leuven (1) · Hospital Ruber Internacional (1) · Elizabeth Anne Thiele (1) · NYU Langone Health (1) · University of Oxford (1)

Often tested with

Tested in the same studies.

Cannabidiol (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 1 in phase 3

Studies that test Fenfluramine, phase 3 first.

Studies

Open first, then newest update. How each study uses Fenfluramine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 22

See all 22 studies that test Fenfluramine →

Codes

What other systems call Fenfluramine · ClinicalTrials.gg INT007480

  • MeSH (NLM) D005277FenfluramineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 2DS058H2CFFENFLURAMINEConfirmed FDA, NLM, Wikidata
  • RxNorm 4328Confirmed FDA, Wikidata
  • Wikidata Q418928(RS)-fenfluramineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81418FenfluramineOne source FDA
  • DrugBank DB00574One source Wikidata

Also registered as fenfluramine hydrochloride (UNII 3KC089243P · RxNorm 82018).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.